The purpose of this clinical research study is to evaluate the effects of an investigational product (setanaxib) as a potential additional treatment for PBC. The study is now enrolling in Ontario: Toronto, London, North Bay and in Calgary, Alberta. To learn more about the TRANSFORM study and whether or not you might be able to participate, click here.
August 21, 2026
No Comments
